Late presentation of Cryptococcus gattii meningitis in a traveller to Vancouver Island: A case report

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 18, Issue 3, 2007, Pages 197-199

  Levy, Ron ^a   Pitout, Johann ^a   Long, Patricia ^b   Gill, M John ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cryptococcus gattii; Disseminated cryptococcosis; Immunocompetent; Meningitis; Pneumocryptococcosis

Indexed keywords

AMPHOTERICIN B; CREATININE; FLUCONAZOLE; FLUCYTOSINE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BLURRED VISION; CANADA; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CREATININE BLOOD LEVEL; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCUS; CRYPTOCOCCUS GATII; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; HYPOGLYCEMIA; HYPOKALEMIA; IMMUNOCOMPETENCE; LUMBAR PUNCTURE; LUNG INFECTION; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PHOTOSENSITIVITY; THORAX RADIOGRAPHY; TRAVEL; VOMITING;

EID: 34547823026     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/319296     Document Type: Article

References (20)

1. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984;120:123-30.
2. Ellis DH. Cryptococcus neoformans var. gattii in Australia. J Clin Microbiol 1987;25:430-1.
3. Pfeiffer T, Ellis D. Environmental isolation of Cryptococcus neoformans gattii from California. J Infect Dis 1991;163:929-30.
4. Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 1995;21:28-34.
5. Mitchell DH, Sorrell TC, Allworth AM, et al. Cryptococcal disease of the CNS in immunocompetent hosts: Influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995;20:611-6.
6. Chen S, Sorrell T, Nimmo G, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis 2000;31:499-508.
7. Ellis DH, Pfeiffer TJ. Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol 1990;28:1642-4.
8. British Columbia Centre for Disease Control. Fungal infection found in Vancouver and Fraser health regions. 〈http://http://www.bccdc.org/news.php? item=118〉 (Version current at June 7, 2007).
9. Stephen C, Lester S, Black W, Fyfe M, Raverty S. Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. Can Vet J 2002;43:792-4.
10. Hoang LM, Maguire JA, Doyle P, Fyfe M, Roscoe DL. Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centte (1997-2002): Epidemiology, microbiology and histopathology. J Med Microbiol 2004;53:935-40.
11. Ikeda R, Shinoda T, Fukazawa Y, Kaufman L. Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates. J Clin Microbiol 1982;16:22-9.
12. The Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. 〈http://www.clsi.org/source/orders/free/m38-a.pdf〉 (Version current at June 7, 2007).
13. Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000;30:710-8.
14. Tsunemi T, Kamata T, Fumimura Y, et al. Immunohistochemical diagnosis of Cryptococcus neoformans var. gattii infection in chronic meningoencephalitis: The first case in Japan. Intern Med 2001;40:1241-4.
15. Kidd SE, Hagen F, Tscharke RL, et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci USA 2004;101:17258-63.
16. Lui G, Lee N, Ip M, et al. Cryptococcus in apparently immunocompetent patients. QJM 2006;99:143-51.
17. MacDougall L, Fyfe M. Emergence of Cryptococcus gattii in a novel environment provides clues to its incubation period. J Clin Microbiol 2006;44:1851-2.
18. Pappas PG, Perfect JR, Cloud GA, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 2001;33:690-9.
19. Zinck SE, Leung AN, Frost M, Berry GJ, Müller NL. Pulmonary cryptococcosis: CT and pathologic findings. J Comput Assist Tomogr 2002;26:330-4.
20. Fox DL, Müller NL. Pulmonary cryptococcosis in immunocompetent patients: CT findings in 12 patients. AJR Am J Roentgenol 2005;185:622-6.